TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases by Jessica | Jan 9, 2023 Read more »
Cellarity Releases Novel, Open-Source, Single-Cell Dataset for NeurIPS 2022 Competition by Jessica | Aug 17, 2022 Read more »
Senda Biosciences Announces Close of $123 Million Series C Financing by Jessica | Aug 16, 2022 Read more »
Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184, a Novel NEK7/NLRP3 Inhibitor by Jessica | Jun 15, 2022 Read more »